Mardi C. Dier
2015
In 2015, Mardi C. Dier earned a total compensation of $2.7M as Executive Vice President and Chief Financial Officer at Portola Pharmaceuticals, a 49% increase compared to previous year.
Compensation breakdown
Bonus | $19,997 |
---|---|
Non-Equity Incentive Plan | $159,975 |
Option Awards | $1,000,210 |
Salary | $390,710 |
Stock Awards | $1,126,115 |
Other | $16,746 |
Total | $2,713,753 |
Dier received $1.1M in stock awards, accounting for 41% of the total pay in 2015.
Dier also received $20K in bonus, $160K in non-equity incentive plan, $1M in option awards, $390.7K in salary and $16.7K in other compensation.
Rankings
In 2015, Mardi C. Dier's compensation ranked 3,539th out of 13,638 executives tracked by ExecPay. In other words, Dier earned more than 74.1% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,539 out of 13,638 | 74th |
Division Manufacturing | 1,288 out of 5,190 | 75th |
Major group Chemicals And Allied Products | 468 out of 1,854 | 75th |
Industry group Drugs | 374 out of 1,528 | 76th |
Industry Pharmaceutical Preparations | 294 out of 1,182 | 75th |
Source: SEC filing on April 24, 2017.
Dier's colleagues
We found three more compensation records of executives who worked with Mardi C. Dier at Portola Pharmaceuticals in 2015.